Latest multiple sclerosis Stories
Risk of MS highest in April and lowest in October, large analysis shows The risk of developing multiple sclerosis (MS) is highest in the month of April, and lowest in October, indicates an analysis of the available evidence, published online in the Journal of Neurology Neurosurgery and Psychiatry. The findings, which include several populations at latitudes greater than 52 degrees from the equator for the first time, strongly implicate maternal exposure to vitamin D during pregnancy....
SEATTLE, Nov. 15, 2012 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today announced that GPR17-targeting compounds, which were previously identified by Omeros in connection with unlocking this orphan receptor, have now been demonstrated to promote differentiation of the cells that form myelin in the central nervous system. Myelin is critical for the proper functioning of the nervous system, and demyelination is associated with multiple nervous system disorders, including...
Barancik Prize largest ever cash prize to spur progress toward a cure for MS NEW YORK, Nov. 12, 2012 /PRNewswire-USNewswire/ -- A new, $100,000 annual cash prize has been established to recognize scientists whose inventive work is propelling measurable multiple sclerosis research progress. MS is an unpredictable, often disabling disease of the central nervous system, which interrupts the flow of information within the brain, and between the brain and body. The Barancik Prize for...
FORT LAUDERDALE, Fla., Nov. 12, 2012 /PRNewswire/ -- The Multiple Sclerosis Foundation presents Fashion Fights MS, a charity Fashion Show and luncheon benefitting the MSF. The event starts at 11 AM Thursday, December 13th, at the iconic Ritz-Carlton Fort Lauderdale located at 1 North Fort Lauderdale Beach Blvd. In addition to gorgeous, drop dead designs, there will be a silent auction and Patrick McClave playing the harp creating an elegant ambience. This memorable Fashion Show...
GAITHERSBURG, Md., Nov. 8, 2012 /PRNewswire/ -- DioGenix, Inc., a company developing molecular diagnostics for the early diagnosis and monitoring of immune-mediated neurological diseases, today announced its lead product MSPrecise(TM) outperformed the specificity of the current standard of care for cerebral spinal fluid (CSF) analysis in patients suspected of having multiple sclerosis (MS) by almost two to one with no loss of sensitivity. MSPrecise is a proprietary...
GAITHERSBURG, Md., Nov. 8, 2012 /PRNewswire/ -- DioGenix, Inc. today announced an alliance with Fast Forward, a subsidiary of the National Multiple Sclerosis Society, to develop a novel blood test for multiple sclerosis (MS). Fast Forward will provide up to $500,000 as part of a Sponsored Research Agreement that will enable DioGenix to expand an ongoing clinical trial of its MS diagnostic, MSPrecise(TM), a proprietary next-generation sequencing assay that measures changes to the...
World-leading experts in Magnetic Resonance Imaging from The University of Nottingham’s Sir Peter Mansfield Magnetic Resonance Centre have made a key discovery which could give the medical world a new tool for the improved diagnosis and monitoring of neuro-degenerative diseases like multiple sclerosis. The new study, published in the Proceedings of the National Academy of Science, reveals why images of the brain produced using the latest MRI techniques are so sensitive to the direction...
Lawrence LeBlond for redOrbit.com - Your Universe Online A new drug to fight multiple sclerosis (MS) is showing promise as one of the “most effective” treatment options ever produced for the debilitating disease, according to UK researchers. The drug, which is used to ‘reboot’ a person’s immune system, has been shown to be effective in MS patients who have already failed to respond to the first drug with which they were treated, as well as those who have gone previously...
ROCKLAND, Mass., Oct. 11, 2012 /PRNewswire/ -- EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, announced today during the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) congress in Lyon, France, that the company has initiated a new global research award to improve understanding of multiple sclerosis for the ultimate benefit of patients. (Logo: http://photos.prnewswire.com/prnh/20101126/SF07905LOGO-a) (Logo:...
LA JOLLA, Calif., Oct. 10, 2012 /PRNewswire/ -- New research directions are being explored to find therapies for hard to treat diseases. One exciting new approach is the use of autologous Adult Stem Cells. Multiple Sclerosis (MS) is one of the many notable diseases adult stem cell therapy could potentially impact. Multiple Sclerosis (MS) is a disorder in which an individual's own immune system attacks the 'myelin sheath'. The myelin sheath serves to protect the nerve cells...
